Athanasios Charalampopoulos

2.6k total citations
66 papers, 966 citations indexed

About

Athanasios Charalampopoulos is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Immunology and Allergy. According to data from OpenAlex, Athanasios Charalampopoulos has authored 66 papers receiving a total of 966 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pulmonary and Respiratory Medicine, 27 papers in Cardiology and Cardiovascular Medicine and 9 papers in Immunology and Allergy. Recurrent topics in Athanasios Charalampopoulos's work include Pulmonary Hypertension Research and Treatments (38 papers), Cardiovascular Function and Risk Factors (17 papers) and Allergic Rhinitis and Sensitization (9 papers). Athanasios Charalampopoulos is often cited by papers focused on Pulmonary Hypertension Research and Treatments (38 papers), Cardiovascular Function and Risk Factors (17 papers) and Allergic Rhinitis and Sensitization (9 papers). Athanasios Charalampopoulos collaborates with scholars based in United Kingdom, Greece and Germany. Athanasios Charalampopoulos's co-authors include David G. Kiely, Robin Condliffe, Charlie Elliot, Julia Grapsa, Petros Nihoyannopoulos, Despoina Vokou, Andrew J. Swift, Gary Dobson, Benjamin Smith and David M. Dawson and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The Science of The Total Environment.

In The Last Decade

Athanasios Charalampopoulos

57 papers receiving 955 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Athanasios Charalampopoulos United Kingdom 18 534 523 122 116 106 66 966
R C Paton United Kingdom 11 103 0.2× 97 0.2× 78 0.6× 79 0.7× 53 0.5× 19 541
Gerald S. Kuncio United States 14 149 0.3× 116 0.2× 44 0.4× 21 0.2× 90 0.8× 16 894
John Plante United States 6 105 0.2× 170 0.3× 11 0.1× 70 0.6× 107 1.0× 23 840
Robert W. Burroughs United States 5 239 0.4× 1.5k 2.8× 20 0.2× 107 0.9× 831 7.8× 8 2.0k
Michael S. Golden United States 10 254 0.5× 1.5k 2.8× 20 0.2× 117 1.0× 884 8.3× 19 2.2k
Makoto Kitamura Japan 17 36 0.1× 234 0.4× 11 0.1× 47 0.4× 232 2.2× 75 1.1k
Masahiro Yamaguchi Japan 18 259 0.5× 192 0.4× 6 0.0× 241 2.1× 299 2.8× 49 839
Hiroyuki Tanaka Japan 13 113 0.2× 470 0.9× 10 0.1× 44 0.4× 204 1.9× 69 734
Anna Axelsson Raja Denmark 16 144 0.3× 611 1.2× 6 0.0× 184 1.6× 101 1.0× 79 943
William F. Johnston United States 20 657 1.2× 271 0.5× 13 0.1× 70 0.6× 490 4.6× 56 1.3k

Countries citing papers authored by Athanasios Charalampopoulos

Since Specialization
Citations

This map shows the geographic impact of Athanasios Charalampopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Athanasios Charalampopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Athanasios Charalampopoulos more than expected).

Fields of papers citing papers by Athanasios Charalampopoulos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Athanasios Charalampopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Athanasios Charalampopoulos. The network helps show where Athanasios Charalampopoulos may publish in the future.

Co-authorship network of co-authors of Athanasios Charalampopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of Athanasios Charalampopoulos. A scholar is included among the top collaborators of Athanasios Charalampopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Athanasios Charalampopoulos. Athanasios Charalampopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thompson, A. A. Roger, Mohammed Akil, Samer Alabed, et al.. (2024). The spectrum of systemic sclerosis-associated pulmonary hypertension: Insights from the ASPIRE registry. The Journal of Heart and Lung Transplantation. 43(10). 1629–1639. 2 indexed citations
2.
Hameed, Abdul, David G. Kiely, Robin Condliffe, et al.. (2024). Do Hemodynamic Definitions of Chronic Thromboembolic Pulmonary Hypertension Distinguish between Distinct Phenotypes of Chronic Thromboembolic Pulmonary Disease?. Annals of the American Thoracic Society. 22(3). 331–338. 1 indexed citations
3.
Alabed, Samer, Michael Sharkey, Krit Dwivedi, et al.. (2024). Artificial intelligence-based echocardiography assessment to detect pulmonary hypertension. ERJ Open Research. 11(3). 592–2024. 1 indexed citations
4.
Garg, Pankaj, Andrew J. Swift, Graham Fent, et al.. (2021). Characterisation of the patients with suspected heart failure: experience from the SHEAF registry. Open Heart. 8(1). e001448–e001448. 10 indexed citations
5.
Garg, Pankaj, Robert A. Lewis, Christopher Johns, et al.. (2021). Cardiovascular magnetic resonance predicts all-cause mortality in pulmonary hypertension associated with heart failure with preserved ejection fraction. International journal of cardiac imaging. 37(10). 3019–3025. 15 indexed citations
6.
Armstrong, Iain, Athanasios Charalampopoulos, Charlie Elliot, et al.. (2021). Elective lower limb orthopedic arthroplasty surgery in patients with pulmonary hypertension. Pulmonary Circulation. 12(1). e12019–e12019. 2 indexed citations
7.
Garg, Pankaj, Steven Wood, Andrew J. Swift, et al.. (2020). Clinical Predictors of All-Cause Mortality in Patients Presenting to Specialist Heart Failure Clinic with Raised NT-ProBNP and no Heart Failure. ESC Heart Failure. 7(4). 1791–1800. 8 indexed citations
8.
Lewis, Robert A., A. A. Roger Thompson, Catherine Billings, et al.. (2020). Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension. European Respiratory Journal. 55(6). 2000041–2000041. 50 indexed citations
9.
Lewis, Robert A., Catherine Billings, Judith Hurdman, et al.. (2020). Maximal Exercise Testing Using the Incremental Shuttle Walking Test Can Be Used to Risk-Stratify Patients with Pulmonary Arterial Hypertension. Annals of the American Thoracic Society. 18(1). 34–43. 12 indexed citations
10.
Billings, Catherine, Robert A. Lewis, Iain Armstrong, et al.. (2018). Incremental Shuttle Walking Test Distance Is Reduced in Patients With Pulmonary Hypertension in World Health Organisation Functional Class I. Frontiers in Medicine. 5. 172–172. 4 indexed citations
11.
Swift, Andrew J., David Capener, Christopher Johns, et al.. (2017). Magnetic Resonance Imaging in the Prognostic Evaluation of Patients with Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 196(2). 228–239. 109 indexed citations
12.
Charalampopoulos, Athanasios, Robin Condliffe, Charlie Elliot, et al.. (2016). Pulmonary Hypertension in Patients with Heart Failure and Preserved Ejection Fraction: Differential Diagnosis and Management. Pulmonary Circulation. 6(1). 3–14. 16 indexed citations
13.
Hurdman, Judith, Catherine Billings, Athanasios Charalampopoulos, et al.. (2016). Pulmonary arterial hypertension associated with congenital heart disease: Comparison of clinical and anatomic–pathophysiologic classification. The Journal of Heart and Lung Transplantation. 35(5). 610–618. 19 indexed citations
14.
Wardle, Andrew J, Athanasios Charalampopoulos, Ingram Schulze‐Neick, et al.. (2015). Feasibility and safety of cardiopulmonary exercise testing in children with pulmonary hypertension. Cardiology in the Young. 26(6). 1144–1150. 11 indexed citations
15.
Charalampopoulos, Athanasios, Luke Howard, Ioanna Tzoulaki, et al.. (2014). Response to Pulmonary Arterial Hypertension Drug Therapies in Patients with Pulmonary Arterial Hypertension and Cardiovascular Risk Factors. Pulmonary Circulation. 4(4). 669–678. 17 indexed citations
16.
Smith, Benjamin, Gary Dobson, David M. Dawson, et al.. (2014). Three-Dimensional Speckle Tracking of the Right Ventricle. Journal of the American College of Cardiology. 64(1). 41–51. 144 indexed citations
17.
Rallidis, Lοukianos S., Constantinos C. Tellis, John Lekakis, et al.. (2012). Lipoprotein-Associated Phospholipase A2 Bound on High-Density Lipoprotein Is Associated With Lower Risk for Cardiac Death in Stable Coronary Artery Disease Patients. Journal of the American College of Cardiology. 60(20). 2053–2060. 41 indexed citations
18.
Rallidis, Lοukianos S., Christos Varounis, Athanasios Charalampopoulos, et al.. (2011). Mild depression versus C-reactive protein as a predictor of cardiovascular death: a three year follow-up of patients with stable coronary artery disease. Current Medical Research and Opinion. 27(7). 1407–1413. 12 indexed citations
19.
Bouki, Konstantina P., Stavroula N. Psychari, Konstantinos Toutouzas, et al.. (2010). Inflammatory markers and plaque morphology: An optical coherence tomography study. International Journal of Cardiology. 154(3). 287–292. 37 indexed citations
20.
Syrigos, K., et al.. (1999). Prognostic Significance of Autoantibodies Against Tropomyosin in Patients with Colorectal Adenocarcinoma. Hybridoma. 18(6). 543–546. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R C Paton Breakdown of academic impact, for papers by Gerald S. Kuncio Breakdown of academic impact, for papers by John Plante Breakdown of academic impact, for papers by Robert W. Burroughs Breakdown of academic impact, for papers by Michael S. Golden Breakdown of academic impact, for papers by Makoto Kitamura Breakdown of academic impact, for papers by Masahiro Yamaguchi Breakdown of academic impact, for papers by Hiroyuki Tanaka Breakdown of academic impact, for papers by Anna Axelsson Raja Breakdown of academic impact, for papers by William F. Johnston
Rankless by CCL
2026